• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锂在亨廷顿病治疗中的标签外使用:病例系列。

Off label use of lithium in the treatment of Huntington's disease: A case series.

机构信息

Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore, Karnataka, India.

出版信息

Indian J Psychiatry. 2013 Jan;55(1):81-3. doi: 10.4103/0019-5545.105522.

DOI:10.4103/0019-5545.105522
PMID:23439971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3574462/
Abstract

Huntington's disease is characterized by choreic movements, psychiatric disorders, striatal atrophy with selective small neuronal loss, and autosomal dominant inheritance. The genetic abnormality is CAG expansion in Huntingtin gene. Newer therapeutic strategies are evolving to treat this progressive disorder. The neuroprotective agents are one such group of drugs being tried. Lithium has been used to treat Huntington's disease in the past due to its neuroprotective effects. Though the precise mechanism of action is not clear, Lithium can directly or indirectly modulate proteins involved in neuronal survival/differentiation which may account for its neuroprotective effects. We report three patients with Huntington's disease in whom Lithium prevented the progression of chorea and also helped stabilize mood.

摘要

亨廷顿病的特征为舞蹈样动作、精神障碍、纹状体萎缩伴选择性小神经元丧失,以及常染色体显性遗传。遗传异常是亨廷顿基因中的 CAG 扩展。目前正在开发新的治疗策略来治疗这种进行性疾病。神经保护剂是正在尝试的一类药物。过去曾使用锂来治疗亨廷顿病,因为它具有神经保护作用。尽管确切的作用机制尚不清楚,但锂可以直接或间接地调节参与神经元存活/分化的蛋白质,这可能是其神经保护作用的原因。我们报告了 3 例亨廷顿病患者,锂可预防舞蹈病的进展,也有助于稳定情绪。

相似文献

1
Off label use of lithium in the treatment of Huntington's disease: A case series.锂在亨廷顿病治疗中的标签外使用:病例系列。
Indian J Psychiatry. 2013 Jan;55(1):81-3. doi: 10.4103/0019-5545.105522.
2
Therapeutic Strategies in Huntington's Disease.亨廷顿病的治疗策略。
J Clin Neurol. 2006 Dec;2(4):213-24. doi: 10.3988/jcn.2006.2.4.213. Epub 2006 Dec 20.
3
CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.CYP46A1 基因治疗揭示了脑胆固醇代谢在亨廷顿病中的作用。
Brain. 2019 Aug 1;142(8):2432-2450. doi: 10.1093/brain/awz174.
4
Imidazoline receptors as a new therapeutic target in Huntington's disease: A preclinical overview.咪唑啉受体作为亨廷顿病的一个新治疗靶点:临床前概述。
Ageing Res Rev. 2024 Nov;101:102482. doi: 10.1016/j.arr.2024.102482. Epub 2024 Sep 3.
5
Neurochemical substrates of rigidity and chorea in Huntington's disease.亨廷顿舞蹈症中强直与舞蹈症的神经化学底物
Brain. 1993 Oct;116 ( Pt 5):1201-22. doi: 10.1093/brain/116.5.1201.
6
Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.用情绪稳定剂锂盐和丙戊酸预处理间充质干细胞可增强亨廷顿舞蹈病小鼠模型的治疗效果。
Exp Neurol. 2016 Jul;281:81-92. doi: 10.1016/j.expneurol.2016.04.003. Epub 2016 Apr 13.
7
Therapeutic Strategies for Huntington's Disease.亨廷顿舞蹈症的治疗策略
Curr Top Behav Neurosci. 2015;22:161-201. doi: 10.1007/7854_2013_250.
8
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.一种与亨廷顿舞蹈症相似的病症与一种新的CAG重复序列扩增有关。
Ann Neurol. 2001 Dec;50(6):373-80. doi: 10.1002/ana.1312.
9
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.一种与亨廷顿舞蹈症相似的疾病与一种新的CAG重复序列扩增有关。
Ann Neurol. 2001 Sep;50(3):373-80.
10
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.CYP46A1是胆固醇降解的限速酶,在亨廷顿舞蹈病中具有神经保护作用。
Brain. 2016 Mar;139(Pt 3):953-70. doi: 10.1093/brain/awv384. Epub 2016 Jan 29.

引用本文的文献

1
An Overview of the Effects of Lithium on Alzheimer's Disease: A Historical Perspective.锂对阿尔茨海默病影响的概述:历史视角
Pharmaceuticals (Basel). 2025 Apr 5;18(4):532. doi: 10.3390/ph18040532.
2
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
3
Lithium Ions as Modulators of Complex Biological Processes: The Conundrum of Multiple Targets, Responsiveness and Non-Responsiveness, and the Potential to Prevent or Correct Dysregulation of Systems during Aging and in Disease.锂离子作为复杂生物过程的调节剂:多个靶点、响应性和非响应性的难题,以及在衰老和疾病期间预防或纠正系统失调的潜力。
Biomolecules. 2024 Jul 25;14(8):905. doi: 10.3390/biom14080905.
4
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.突变型亨廷顿蛋白分子通路解析为药物重定位提供新靶点。
Int J Mol Sci. 2023 Nov 27;24(23):16798. doi: 10.3390/ijms242316798.
5
An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.精神活性药物锂作为神经退行性疾病中自噬调节剂的神经营养和神经保护特性概述
Cureus. 2023 Aug 24;15(8):e44051. doi: 10.7759/cureus.44051. eCollection 2023 Aug.
6
Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review.神经退行性疾病中精神病症状的诊断和管理进展:叙事性综述。
J Geriatr Psychiatry Neurol. 2023 Nov;36(6):435-460. doi: 10.1177/08919887231164357. Epub 2023 Mar 20.
7
Untangling the Role of Tau in Huntington's Disease Pathology.解开 Tau 在亨廷顿病病理学中的作用。
J Huntingtons Dis. 2023;12(1):15-29. doi: 10.3233/JHD-220557.
8
Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward.糖原合酶激酶-3抑制剂:十年以来中枢神经系统的临床前和临床研究重点
Front Mol Neurosci. 2022 Jan 21;14:792364. doi: 10.3389/fnmol.2021.792364. eCollection 2021.
9
Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.罕见神经退行性疾病的当前药物再利用策略
Front Pharmacol. 2021 Dec 21;12:768023. doi: 10.3389/fphar.2021.768023. eCollection 2021.
10
as a Model Organism to Study Lithium and Boron Bioactivity.作为研究锂和硼生物活性的模式生物。
Int J Mol Sci. 2021 Oct 28;22(21):11710. doi: 10.3390/ijms222111710.

本文引用的文献

1
The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms.心境稳定剂丙戊酸和锂通过不同的机制增强间充质干细胞的迁移。
Neuropsychopharmacology. 2010 Oct;35(11):2225-37. doi: 10.1038/npp.2010.97. Epub 2010 Jul 7.
2
Therapeutic Strategies in Huntington's Disease.亨廷顿病的治疗策略。
J Clin Neurol. 2006 Dec;2(4):213-24. doi: 10.3988/jcn.2006.2.4.213. Epub 2006 Dec 20.
3
Huntington's disease: pathogenesis to animal models.亨廷顿病:从发病机制到动物模型。
Pharmacol Rep. 2010 Jan-Feb;62(1):1-14. doi: 10.1016/s1734-1140(10)70238-3.
4
Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.锂预防神经退行性疾病的潜在机制。
CNS Neurosci Ther. 2009 Winter;15(4):333-44. doi: 10.1111/j.1755-5949.2009.00086.x.
5
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.锂在双相情感障碍治疗中的作用:作为统一假说的神经营养作用的汇聚证据。
Bipolar Disord. 2009 Jun;11 Suppl 2(Suppl 2):92-109. doi: 10.1111/j.1399-5618.2009.00714.x.
6
Review of lithium effects on brain and blood.锂对脑和血液影响的综述。
Cell Transplant. 2009;18(9):951-75. doi: 10.3727/096368909X471251. Epub 2009 May 13.
7
Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.锂与神经精神治疗学:通过糖原合酶激酶-3β、β-连环蛋白和神经营养因子级联反应实现的神经可塑性
J Pharmacol Sci. 2009 May;110(1):14-28. doi: 10.1254/jphs.09r02cr. Epub 2009 May 8.
8
[The role of lithium in neurodegenerative diseases: new registries for old actors].
Neurologia. 2009 Apr;24(3):143-6.
9
Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3beta and beta-catenin/TCF pathway.糖皮质激素和锂通过糖原合成酶激酶-3β(GSK-3β)和β-连环蛋白/TCF途径相互调节成年齿状回来源神经前体细胞的增殖。
Neuropsychopharmacology. 2009 Feb;34(3):805-15. doi: 10.1038/npp.2008.198. Epub 2008 Nov 12.
10
Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation.锂通过激活经典Wnt信号通路来调节成年海马祖细胞的发育。
Mol Psychiatry. 2008 Mar;13(3):285-92. doi: 10.1038/sj.mp.4002093. Epub 2007 Oct 30.